(HealthDay)—For people suffering from clots in their legs, a new study finds that one of two commonly used blood thinners is safer and more effective than the other.
Dec 7, 2021
0
5
No aspect of SARS-CoV-2 infection has been more startling—or problematic—than the elevated risk for blood clotting, a concern that throughout the pandemic has been associated with severe COVID-19, frequently characterized ...
Venous thromboembolism (VTE) refers to blood clots in the veins, which is a serious yet preventable medical condition and is often seen with advanced cancers. Researchers at Rutgers Cancer Institute of New Jersey explored ...
Sep 13, 2021
0
2
Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for COVID-19, ...
Aug 27, 2021
2
1427
The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, "Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert ...
Aug 4, 2021
0
313
(HealthDay)—Children with inflammatory bowel disease (IBD) have a higher risk for venous thromboembolism (VTE), according to a study published online June 27 in the Journal of Crohn's & Colitis.
Jul 27, 2021
0
4
(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is increased after unprovoked ...
Jul 23, 2021
0
4
(HealthDay)—A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).
Jul 20, 2021
0
2
In addition to sickening and taking the lives of millions across the globe, COVID-19 complicated patient care in a range of less-direct ways, from increased incidence of heart attacks to decreased cancer screenings. The virus ...
Jun 28, 2021
0
3
(HealthDay)—Prophylactic-dose venous thromboembolism (VTE) anticoagulation may be optimal therapy for patients hospitalized with COVID-19, according to a study published online June 11 in JAMA Network Open.
Jun 23, 2021
0
0
